RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000071.xml
PDF herunterladen
Semin Neurol 2003; 23(3): 231-240
DOI: 10.1055/s-2003-814743
DOI: 10.1055/s-2003-814743
Current Issues in the Diagnosis and Management of Dementia
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
14. Januar 2004 (online)
ABSTRACT
Aging, memory loss, Alzheimer's disease, and other forms of dementia assume increasing importance to patients, physicians, and society as our population becomes older. Mild cognitive impairment, topography and semiology of dementia syndromes, reversible forms of dementia, dementia therapy, driving, genetic testing of patients and family members, and caregiver risk are reviewed.
KEYWORDS
Alzheimer's disease - dementia - memory loss - dementia with Lewy bodies - memory - mild cognitive impairment - reversible dementia
REFERENCES
- 1 Morris J C, Storandt M, Miller J P. et al . Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol . 2001; 58 397-405
- 2 Petersen R C, Doody R, Kurz A. et al . Current concepts in mild cognitive impairment. Arch Neurol . 2001; 58 1985-1992
- 3 Dubinsky R M, Stein A C, Lyons K. Risk of driving and Alzheimer's disease (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology . 2000; 54 2205-2211
- 4 Caselli R J, Reiman E M, Stelmach G E. et al . Progressive apraxia in clinically discordant monozygotic twins. Arch Neurol . 1995; 52 1004-1010
- 5 Caselli R J, Stelmach G E, Caviness J N. et al . A kinematic study of progressive apraxia with and without dementia. Mov Disord . 1999; 14 276-287
- 6 Caselli R J, Jack Jr R C, Petersen R C. et al . Asymmetric cortical degenerative syndromes: Clinical and radiologic correlations. Neurology . 1992; 42 1462-1468
- 7 Caselli R J, Jack Jr R C. Asymmetrical cortical degeneration syndromes: a proposed clinical classification. Arch Neurol . 1992; 49 770-780
- 8 Caselli R J. Asymmetric cortical degeneration: syndromes and diseases. Neurologist . 1995; 1 1-20
- 9 Caselli R J. Asymmetric cortical degeneration syndromes. Curr Opin Neurol . 1996; 9 276-280
- 10 Boeve B F, Maraganore D M, Parisi J E. et al . Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology . 1999; 53 795-800
- 11 Caselli R J. Corticobasal degeneration: its relationship to other asymmetric cortical degenerative syndromes. Adv Neurol . 2000; 82 35-51
- 12 Caselli R J. Visual syndromes as the presenting feature of degenerative brain disease. Semin Neurol . 2000; 20 139-144
- 13 Caselli R J. Topography, histology, and seminology in dementia (letter). Arch Neurol . 2000; 57 899
- 14 Caselli R J, Beach T G, Sue L I, Connor D J, Sabbagh M N. Progressive aphasia with Lewy bodies. Dement Geriatr Cogn Disord . 2002; 14 55-58
- 15 Caselli R J, Boeve B F, Scheithauer B W. et al . Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology . 1999; 53 1579-1581
- 16 McKeith I G, Galasko D, Kosaka K. et al . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology . 1996; 47 1113-1124
- 17 Caselli R J, Couce M E, Osborne D. et al . From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease. Alzheimer Dis Assoc Disord . 1998; 12 251-253
- 18 Boeve B F, Silber M H, Ferman T J, Lucas J A, Parisi J E. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord . 2001; 16 622-630
- 19 Shumaker S A, Legault C, Rapp S R. et al . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The women's health initiative memory study: a randomized controlled trial. JAMA . 2003; 289 2651-2662
- 20 Aisen P S, Schafer K A, Grundman M. et al . Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression. A randomized controlled trial. JAMA . 2003; 289 2819-1826
- 21 Morris J C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology . 1993; 43 2412-2414
- 22 Hunt L, Morris J C, Edwards D, Wilson B S. Driving performance in persons with mild senile dementia. J Am Geriatr Soc . 1993; 41 747-752
- 23 Flitten L J, Perryman K M, Wilkinson C J. et al . Alzheimer and vascular dementias and driving. JAMA . 1995; 273 1360-1365
- 24 Hunt L A, Murphy C F, Carr D, Duchek J M, Buckles V, Morris J C. Reliability of the Washington University Road Test: a performance based assessment for drivers with dementia of the Alzheimer type. Arch Neurol . 1997; 54 707-712
- 25 Fox G K, Bowden S C, Bashford G M, Smith D S. Alzheimer disease and driving: prediction and assessment of driving performance. J Am Geriatr Soc . 1997; 45 949-953
- 26 Duchek J M, Hunt L, Ball K, Buckles V, Morris J C. Attention and driving performance in Alzheimer's disease. J Gerontol . 1998; 53 130-141
- 27 Rebok G W, Keyl P M, Bylsma F W, Blaustein M J, Tune L. The effects of Alzheimer's disease on driving-related abilities. Alzheimer Dis Assoc Disord . 1994; 8 228-240
- 28 Rizzo M, Reinach S, McGehee D, Dawson J. Simulated car crashes and crash predictors in Alzheimer disease. Arch Neurol . 1997; 54 545-551
- 29 Cox D J, McQuillian W C, Thorndike F P, Kovatchev B P, Hanna G. Evaluating driving performance of outpatients with Alzheimer's disease. J Am Board Fam Pract . 1998; 11 264-271
- 30 Drachman D A, Swearer J M. Driving and Alzheimer's disease: the risk of crashes. Neurology . 1993; 43 2448-2456
- 31 Logsdon R G, Teri L, Larson E B. Driving and Alzheimer's disease. J Gen Intern Med . 1992; 7 583-588
- 32 Sherrington R, Rogaev E L, Liang Y. et al . Cloning of a gene bearing missense mutation in early-onset familial Alzheimer's disease. Nature . 1995; 375 754-760
- 33 Wisniewski K E, Wiesniewski H M, Wen G Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol . 1985; 17 278-282
- 34 Levy-Lahad E, Wasco W, Pookaj P. et al . Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science . 1995; 269 973-977
- 35 Hardy J, Higgins G. Alzheimer's disease-the amyloid cascade hypothesis. Science . 1992; 256 184-185
- 36 Corder E H, Saunders A M, Strittmatter W J. et al . Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science . 1993; 261 921-923
- 37 Saunders A M, Strittmatter W J, Schmechel D. et al . Association of apolipoprotein E e4 allele with late onset familial and sporadic Alzheimer's disease. Neurology . 1993; 43 1467-1472
- 38 Ertekin-Taner N, Graff-Radford N R, Younkin L H. et al . Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science . 2000; 290 2303-2304
- 39 Wu W S, Holmans P, Wavrant-DeVrieze F. et al . Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA . 1998; 280 619-622
- 40 Caselli R J, Reiman E M, Hentz J G, Osborne D, Alexander G E, Boeve B F. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep . 2002; 25 447-453
- 41 Caselli R J, Reiman E M, Hentz J G, Osborne D, Alexander G E. A distinctive interaction between chronic anxiety and problem solving in APOE e4 homozygotes (in press). J Neuropsychiatry Clin Neurosci.
- 42 Caselli R J, Graff-Radford N R, Reiman E M. et al . Preclinical memory decline in cognitively normal apolipoprotein E-e4 homozygotes. Neurology . 1999; 53 201-207
- 43 Caselli R J, Osborne D, Reiman E M. et al . Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J Neurol Sci . 2001; 189 93-98
- 44 Baxter L C, Caselli R J, Johnson S C, Reiman E M, Osborne D. Apolipoprotein E varepsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging . 2003; 24 947-952
- 45 Reiman E M, Caselli R J, Yun L S. et al . Preclinical evidence of a genetic risk factor for Alzheimer's disease in apolipoprotein E type 4 homozygotes using positron emission tomography (with editorial). N Engl J Med . 1996; 334 752-758
- 46 Reiman E M, Caselli R J, Chen K, Alexander G E, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E e4 heterozygotes: a foundation for testing Alzheimer's dementia prevention therapies. Proc Natl Acad Sci U S A . 2001; 98 3334-3339
- 47 Reiman E M, Caselli R J, Alexander G E, Chen K. Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease. Clin Neurosci Res . 2001; 28 194-206
- 48 Reiman E M, Chen K, Alexander G E. et al . Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (in press). Proc Natl Acad Sci.
- 49 Relkin N R, Kwon Y J, Tsai J, Gandy S. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci . 1996; 802 149-176
- 50 Eastley R, Wilcock G K. Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease. Int J Geriatr Psychiatry . 1997; 12 484-487
- 51 Mendez M F, Perryman K M, Miller B L, Cummings J L. Behavioral differences between frontotemporal dementia and Alzheimer's disease: a comparison on the BEHAVE-AD rating scale. Int Psychogeriatr . 1998; 10 155-162